Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
about
DNA Damage and Pulmonary HypertensionIn vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular systemThe dual regulatory role of miR-204 in cancerSex differences in the pulmonary circulation: implications for pulmonary hypertensionDehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptorAdventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell.Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.Heme biosynthesis modulation via δ-aminolevulinic acid administration attenuates chronic hypoxia-induced pulmonary hypertension.Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.Mechanisms and therapeutic potential of microRNAs in hypertension.Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes.Regulation of ca(2+) signaling in pulmonary hypertension.Targeted inhibition of survivin with YM155 promotes apoptosis of hypoxic human pulmonary arterial smooth muscle cells via the upregulation of voltage-dependent K⁺ channelsHigher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.Signal transduction in the development of pulmonary arterial hypertensionGender, sex hormones and pulmonary hypertension.Thioredoxin-interacting protein regulates insulin transcription through microRNA-204Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathwayPulmonary arterial hypertension: basis of sex differences in incidence and treatment response.Role of microRNAs in Vascular Remodeling.Relationships between vascular oxygen sensing mechanisms and hypertensive disease processes.Reactive oxygen species as therapeutic targets in pulmonary hypertension.The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future.STAT3 signaling in pulmonary arterial hypertension.Progress in solving the sex hormone paradox in pulmonary hypertension.Control of vascular smooth muscle function by Src-family kinases and reactive oxygen species in health and disease.Novel investigational therapies for treating pulmonary arterial hypertension.Advances in treatment of pulmonary arterial hypertension: patent review.The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies.Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.Update on novel targets and potential treatment avenues in pulmonary hypertension.Update on innovative initiatives for the American Journal of Physiology-Heart and Circulatory Physiology.Emerging Therapeutics in Pulmonary Hypertension.Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series).Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
P2860
Q27005594-C24FA741-D654-4C3F-AE58-8ED75A72F316Q27026337-AB881223-4762-4BFC-A12F-E2DDC4498099Q28078421-A0C2FDEE-ED34-45EF-B95F-05D5C6889597Q33568826-F35A8DA0-A045-4FE5-ADD8-36062234C126Q33820667-F2F1FCDC-E56B-422C-9C30-FD5DABE91AADQ33909537-99AE767B-CCAA-42B2-9A56-17D2BE10776BQ33977405-A0833C38-4837-411A-BDDB-869C14BD3ACFQ34317717-597D736A-46A6-42BE-BEA9-8AC4C92680E2Q34958933-3A952D79-0661-40AF-8870-F04124FBA65BQ35275372-19E17AA9-170A-43DC-B4DC-D9D81CAFA947Q35919662-B60D8A6B-C668-46F1-AB88-21F4B6CEE1A9Q36016478-9CDDFD49-8BE6-46D7-95CE-A50848706A29Q36173562-9E3D449A-EBEF-48EA-A44F-9C13E5642121Q36422429-84F6C363-4685-46D8-90BB-05154286F431Q36628777-04FF3EAC-3A47-4D32-97AB-E87820304DDBQ36722236-2E13EDAC-DD3E-470B-996A-2E3ED26EB293Q36916062-6FD20C74-2412-4F10-8578-4256E4AB388BQ37133785-52E0831D-057C-4BA4-9DFF-5A33879774ACQ37133789-1C4B0F06-8ACA-4CC9-AC9F-14830E9F26CBQ37330393-BC411B39-E57F-4273-87F5-DA65D6CE88EDQ37596153-13175769-3D8B-4EC6-9598-AC81EFC4BFF0Q37671277-5067F8B4-4809-410F-80E5-D0342E557F1DQ37741544-1BC32098-3644-47B5-BCD6-A4B7CC1A32C8Q38019769-1F55F0B3-B953-4654-8AAD-B997AA5A31C6Q38074770-22762B70-C44E-4AE7-9A28-40BFA63DFF90Q38077796-E35F6F91-E013-42DC-B9DC-D46F13F34466Q38140894-62E4062E-9237-46C0-9307-BBF2326DB281Q38210880-805A6233-BF51-4399-A638-E829050E6823Q38266683-8C416312-9768-4146-AF1C-B04BCBD83E65Q38612061-96BD28F7-C9F7-4CB9-9D53-0745E957F0D8Q39206788-BC4AD9C6-FDFC-4F10-AB25-62429BFEC912Q39353707-BAA2071F-51F1-4A9F-A937-2DAC7C128993Q42746715-CC226690-F7A8-4FE6-8682-39D5FBF16ABAQ42784219-9C09024F-3DDE-4A03-B52F-D3299EB8381DQ44132620-93618C6C-54FF-44AC-AC25-BFCFDA17F39FQ47700134-0E711322-BA6C-4542-89F4-183811AB82D7Q51069073-DAA48CA5-16ED-45C1-959B-9E59DBF21DDEQ55008475-7F626EE5-5569-4807-A87E-CE847D38126EQ58800964-5E0CEE68-5C6A-4779-B879-51F5C742B01B
P2860
Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Dehydroepiandrosterone inhibit ...... lmonary arterial hypertension.
@en
Dehydroepiandrosterone inhibit ...... lmonary arterial hypertension.
@nl
type
label
Dehydroepiandrosterone inhibit ...... lmonary arterial hypertension.
@en
Dehydroepiandrosterone inhibit ...... lmonary arterial hypertension.
@nl
prefLabel
Dehydroepiandrosterone inhibit ...... lmonary arterial hypertension.
@en
Dehydroepiandrosterone inhibit ...... lmonary arterial hypertension.
@nl
P2093
P2860
P1476
Dehydroepiandrosterone inhibit ...... ulmonary arterial hypertension
@en
P2093
Audrey Courboulin
Jolyane Meloche
Maria Helena Jacob
Roxane Paulin
Sébastien Bonnet
P2860
P304
P356
10.1152/AJPHEART.00654.2011
P577
2011-09-02T00:00:00Z